📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Chemogenetic Silencing of NaV1.8-Positive Sensory Neurons Reverses Chronic Neuropathic and Bone Cancer Pain in FLEx PSAM4-GlyR Mice. (2023)

First Author: Haroun R

Attributed to: MICA: Development and Validation of a Transcriptomic-Based Model for Classifying and Predicting Treatment Response in Rheumatoid Arthritis (TRACT-RA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1523/eneuro.0151-23.2023

PubMed Identifier: 37679042

Publication URI: http://europepmc.org/abstract/MED/37679042

Type: Journal Article/Review

Volume: 10

Parent Publication: eNeuro

Issue: 9

ISSN: 2373-2822